"Nyrada will provide WRAIR with sufficient drug quantities to complete the study, and US$150,000 to cover key costs associated with the work."
NYR are paying for a report ( which is now two years overdue). The report will probably say "this drug show promise, give us a few million and we'll run some more tests for you".
This will not be "guaranteed non-dilutive funding" that people on here will have you believe.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-179
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 07.10am 01/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable